CompletedNot Applicable

Complex Decongestive Physiotherapy Applied After Lymphovenous Anastomosis Surgery

Turkey (Türkiye)26 participantsStarted 2023-08-21

Plain-language summary

Type of this study: Prospective randomized controlled study. The aim of our study is to compare patients with lymphedema who have undergone lymphovenous anastomosis surgery receiving Complex Decongestive Physiotherapy (CDP), patients with lymphedema who have not undergone surgery who receive Complex Decongestive Physiotherapy, in terms of Extremity Volume, Quality of Life and Patient Satisfaction. 26 volunteers will be included in the study as patients with lymphedema who have undergone lymphovenous anastomosis surgery and KBF (n=13), only KBF (n=13), application groups. How effective is lymphovenous anastomosis surgery and KBF or only CDP acutely in the treatment of lymhedema?

Who can participate

Age range

18 Years – 65 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Between the ages of 18-65, * Having unilateral lower extremity or upper extremity lymphedema, * Being diagnosed with Stage 2 and 3 lymphedema, * Receiving lymphedema therapy for the first time, * Adjuvant chemotherapy for gynecological cancer, * Having completed radiation and surgical treatment at least 3 months and at most 5 years ago, * Patients with lymph vessels seen on lymphangiography, * Patients who have undergone LVA surgery and 1 month has passed since the surgery date * No evidence of disease recurrence at last follow-up visit and * Individuals willing to participate in the study Exclusion Criteria: * Those who do not volunteer to participate in the study, * Those with bilateral lower extremity lymphedema, * Having upper or lower extremity edema due to systemic disease, * Those with active infection, * Patients more than 1.5 months after LVA surgery * Known to have mental and cognitive disorders * Those who were unable to communicate and cooperate were not included.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Tape Measure

Timeframe: 5 months

Trial details

NCT IDNCT06167993

SponsorNecmettin Erbakan University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-08-21

View on ClinicalTrials.gov More Lymphedema trials